Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Top 15 Most Undervalued Biotech Stocks By Analyst Target Price
Top 15 Most Undervalued Biotech Stocks By Analyst Target Price
Top 15 Most Undervalued Biotech Stocks By Analyst Target Price
Submitted by
admin
on April 9, 2011 - 11:02am
Source:
Seeking Alpha
News Tags:
Prolor
Lexicon Pharmaceuticals
Dendreon
Human Genome Sciences
Targacept
Sequenom
Cadence Pharmaceuticals
Savient
ONYX Pharmaceuticals
Amylin
Emergent BioSolutions
XenoPort
Spectrum Pharmaceuticals
Incyte
Amgen
Headline:
Top 15 Most Undervalued Biotech Stocks By Analyst Target Price
Do Not Allow Advertisers to Use My Personal information
